About this trial
This is a biological study based on a collaborative effort involving several Italian haematology centres (including the coordinating centre). The study will be conducted retrospectively and prospectively using bone marrow (BM) or peripheral blood (PB) samples, lymph node or tissue biopsies with metastatic involvement, and other biological fluids, such as cerebrospinal fluid and pathological pleural effusion.
Eligibility criteria
Qualifiers
Patient aged > 2 year old
Patients previously diagnosed with hematological malignancies
Patients with clinical suspect of hematological malignancies requiring a diagnostic assessment using BM or PB samples, biopsies of lymph nodes or tissues with metastatic involvement, or other biological fluids (such as CSF, pathologic pleural effusion).
Patients with clinical suspicion of R/R onco-hematological disorder, requiring a diagnostic assessment using BM aspirate/biopsy or biopsies of tissues with metastatic involvement including lymph nodes, liquor from lumbar puncture, tissue aspirate etc.
Disqualifiers
Age <2 year old
Patient without a diagnosis of hematological malignancy.
Trial design
Treatments tested in this trial
- Multi-omics analyses
- Functional tests
Treatment groups
Sponsors and collaborators
Azienda Ospedaliero-Universitaria di Parma
Lead sponsor
University of Parma
Sponsor institution